Giving babies the best start.
Hospitals across the country of all sizes and NICU acuity levels trust Mednax to deliver comprehensive care to critically-ill and premature newborns while improving outcomes, enhancing the parent/patient experience and reducing costs. As an industry leader celebrating 40 years of successful hospital partnerships, we bring unparalleled expertise and the resources of a national medical group to the communities we serve.
Quality is expected. We deliver more.
Real-time quality measurement tools and success tracking, including the world’s most comprehensive neonatal patient outcomes database, gives us the insight we need to drive meaningful change.
Continuous quality improvement and safety initiatives are customized to meet the needs of each hospital.
Our groundbreaking 100,000 Babies Campaign serves as the foundation of our neonatal quality programs with proven results: decreased mortality, decreased central line infections, decreased retinopathy of prematurity, increased use of breast milk and more.
NICU-specific HRO and simulation programs help improve quality, communication, safety and the parent/patient experience.
On-site education is routine with a wide range of topics for staff nurses, respiratory therapists and other members of the NICU team.
Clinical/operational expertise and physician leadership supports our efforts to reduce transfers out and build volume.
We can provide comprehensive newborn solutions including newborn hospitalist services, newborn hearing screens and telemedicine programs to detect retinopathy of prematurity.
Our neonatal patient outcomes database is the world’s most comprehensive and robust with 1.2M+ patients and 23M+ patient days.
Mednax 40 years of transforming health care
* Numbers represent our NICU service line.
Our multi-specialty and ancillary services expertise helps us deliver coordinated, customized solutions in response to your changing needs. Explore our family of companies and solutions:
Learn more about Mednax at an upcoming event.
No Events on The List at This Time